highly significantP < .0001
As shown in Figure 4 , the diagnostic power of C6Ma1 and C6Ma3 was highly significant with an AUROC of 0.90 ( P < .0001) and of 0.87 ( P < .0001), respectively when comparing healthy control to patients with cancer.
As shown in Figure 4 , the diagnostic power of C6Ma1 and C6Ma3 was highly significant with an AUROC of 0.90 ( P < .0001) and of 0.87 ( P < .0001), respectively when comparing healthy control to patients with cancer.
These findings indicate that PRO-C6 could be prognostic in cancer, which is also supported by the borderline significant association between cancer stage and PRO-C6 levels ( P = .072, when comparing early vs late stage patients).